Cara Therapeutics CARA reported its Q4 earnings results on Monday, March 4, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Cara Therapeutics missed estimated earnings by -44.0%, reporting an EPS of $-0.59 versus an estimate of $-0.41.
Revenue was down $257 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 7.000000000000001% drop in the share price the next day.
Here's a look at Cara Therapeutics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.52 | -0.56 | -0.52 | -0.32 |
EPS Actual | -0.52 | -0.58 | -0.49 | -0.56 |
Revenue Estimate | 9.95M | 6.49M | 4.98M | 16.25M |
Revenue Actual | 4.87M | 6.93M | 6.17M | 3.26M |
To track all earnings releases for Cara Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.